OPHTHALMIC SITUATION OF THE PATIENTS WITH CHRONIC RENAL FAILURE UNDERGOING HEMODIALYSIS
Öz
ABSTRACT
Background/Aims: Hemodialysis (HD) is a unique treatment modality for patients with end-stage chronic renal failure (ESCRF). A wide range of ophthalmologic findings such as refractive changes, dry eye, increased intraocular pressure and retinal hemorrhage can be seen in these patients. In this study, we aimed to evaluate the ophthalmological status of hemodialysis patients.
Methods: A total of 504 eyes of 252 patients with ESCRF undergoing hemodialysis were included in the study. Renal failure, hemodialysis and additional disease data were evaluated along with demographic data of all patients. All participants underwent a total ophthalmological examination including visual acuity, intraocular pressure, detailed anterior and posterior segment examination.
Results: The mean age was 65.2113.15 years, and the mean hemodialysis time was 4.954.25 years. 237 (47.2%) of 504 eyes were pseudo-phakic and 170 (33.7%) had cataracts at different stages. Diabetic retinopathy (DRP) findings were detected in a total of 148 (26.4%) eyes. Age-related macular degeneration (AMD) findings at various stages were observed in 112 eyes (22.1%), while epiretinal membranes were detected in 60 eyes (11.9%). Dry eye findings were observed in 94 cases (37.1%) and glaucoma was detected in 20 cases.
Conclusions: The most common sight-threatening condition in ESCRF patients appears to be cataract and the most common ocular surface problem was dry eye disease. While various retinal pathologies were observed in a significant part of the patients, the frequency of proliferative DRP was found to be higher than that in the diabetic population.
Anahtar Kelimeler
hemodialysis, chronic renal disease, renal failure, ophthalmologic findings, visual loss
Kaynakça
- 1. Sgambat K, Cheng YI, Charnaya O, Moudgil A. The prevalence and outcome of children with failure to thrive after pediatric kidney transplantation. Pediatr Transplant. 2019;23(1):e13321.
- 2. Agarwal R. Defining end-stage renal disease in clinical trials: a framework for adjudication. Nephrol Dial Transplant. 2016;31(6):864-867.
- 3. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587-2593.
- 4. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
- 5. Evans RD, Rosner M, editors. Fellows’ forum: Ocular abnormalities associated with advanced kidney disease and hemodialysis. Seminars in dialysis; 2005: Wiley Online Library.
- 6. Wong CW, Lamoureux EL, Cheng CY, Cheung GC, Tai ES, Wong TY, et al. Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study. EBioMedicine. 2016;5:193-197.
- 7. Mullaem G, Rosner MH. Ocular problems in the patient with end-stage renal disease. Semin Dial. 2012;25(4):403-407.
- 8. Nusinovici S, Sabanayagam C, Teo BW, Tan GSW, Wong TY. Vision Impairment in CKD Patients: Epidemiology, Mechanisms, Differential Diagnoses, and Prevention. Am J Kidney Dis. 2019;73(6):846-857.
- 9. Rim TH, Yoon CY, Park HW, Chung EJ. Association Between Starting Hemodialysis for End-Stage Renal Disease and Incident Cataract Surgery: A 12-Year Nationwide Cohort Study. Invest Ophthalmol Vis Sci. 2016;57(3):1112-1119.
- 10. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615-621.